IPSEN |
Market Closed -
Other stock markets
|
After market 18:42:03 | |||
| 120.8 EUR | -0.49% |
|
121 | +0.12% |
| 05-14 | Ipsen: share price up, analyst raises target | CF |
| 05-14 | IPSEN : Barclays raises its target price | CF |
ETFs positioned on Ipsen
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.83% | 2 M€ | +11.54% | ||
| 0.43% | 242 M€ | +9.62% | ||
| 0.31% | 3 M€ | +9.95% | - | |
| 0.24% | 1,083 M€ | +4.65% | ||
| 0.24% | 5 M€ | +4.56% | ||
| 0.16% | 14 M€ | +5.66% | - | |
| 0.16% | 5 M€ | +10.09% | - | |
| 0.10% | 2 M€ | +9.19% | - | |
| 0.10% | 2 M€ | -.--% | - | |
| 0.09% | 17 M€ | +7.73% | - | |
| 0.05% | 6 M€ | -.--% | - | |
| 0.04% | 6 M€ | -.--% | ||
| 0.03% | 32 M€ | +9.07% | - | |
| 0.03% | 10 M€ | -3.35% | - | |
| 0.02% | 7 M€ | +0.11% | - | |
| 0.02% | 23 M€ | -.--% | - | |
| 0.02% | 786 M€ | -.--% | ||
| 0.01% | 206 M€ | -.--% | ||
| 0.01% | 607 M€ | +0.05% | - | |
| 0.01% | 1,166 M€ | +0.26% | - | |
| 0.01% | 283 M€ | +20.56% | ||
| 0.00% | 45 M€ | 0.00% | - | |
| 0.00% | 284 M€ | -.--% | ||
| 0.00% | 391 M€ | +9.28% | - | |
| 0.00% | 34 M€ | +9.38% | - | |
| 0.00% | 34 M€ | +4.28% | - |
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
Pharmaceuticals
Calendar
28/05/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
121.4
EUR
Average target price
126.3
EUR
Spread / Average Target
+4.07%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.96% | 10.9B | |
| +32.29% | 694B | |
| +29.39% | 593B | |
| -1.58% | 371B | |
| +19.94% | 331B | |
| +7.29% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.73% | 169B |
- Stock Market
- Equities
- IPN Stock
- Funds and ETFs Ipsen
